Compare ACET & FLNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACET | FLNT |
|---|---|---|
| Founded | 1947 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.6M | 92.5M |
| IPO Year | 2017 | 2009 |
| Metric | ACET | FLNT |
|---|---|---|
| Price | $6.90 | $3.36 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $65.33 | $2.50 |
| AVG Volume (30 Days) | ★ 174.7K | 23.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.82 | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $254,623,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $11.71 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $1.50 |
| 52 Week High | $9.05 | $4.00 |
| Indicator | ACET | FLNT |
|---|---|---|
| Relative Strength Index (RSI) | 47.96 | 49.14 |
| Support Level | $6.41 | $1.80 |
| Resistance Level | $8.46 | $3.57 |
| Average True Range (ATR) | 0.52 | 0.22 |
| MACD | -0.08 | -0.02 |
| Stochastic Oscillator | 44.87 | 49.63 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
Fluent Inc is a data-driven digital marketing services company. It performs customer acquisition services by operating digital marketing campaigns, through which it connects its advertiser clients with consumers company is seeking to reach. It delivers data and performance-based marketing executions to its clients, such as consumer brands, direct marketers and agencies across a wide range of industries, including Financial Products & Services, Media & Entertainment, Health & Wellness, Staffing & Recruitment and Retail & Consumer.